期刊文献+

门诊与住院治疗缓解期精神分裂症患者病耻感的对照研究 被引量:9

A comparison study on stigma of schizophrenia in remission between outpatients and inpatients
原文传递
导出
摘要 目的通过对门诊与住院治疗精神分裂症患者的病耻感评估,分析不同治疗环境对精神分裂症病耻感的影响。方法对浙江省立同德医院门诊和住院治疗的缓解期精神分裂症患者各70例进行人口学特征、精神病简明评定量表(BPRS)、PANSS量表、副反应量表、临床疗效总评量表严重度(CGI-SI)和病耻感量表进行测量和评估,比较门诊与住院患者缓解期病耻感特点。结果两组精神分裂症患者普遍存在被歧视、自我感觉的病耻感及对疾病的掩饰性,但经过住院治疗的患者对病耻感的掩饰性因子(2.01±0.88)分和积极效应因子(1.68±0.78)分低于门诊治疗的患者(2.43±0.98)和(2.44±0.78)分,差异均有统计学意义(P<0.05)。结论门诊治疗对减轻耻感、提高生活质量相当重要。严格遵守和执行精神卫生法,可以较大限度地保护精神病患者的合法权益。 Objective To analyze the influence of different therapeutic environments on stigma of schizophrenia patients.Methods A total of 70 outpatients and 70 inpatients with schizophrenia in remission in Tongde hospital of Zhejiang province were enrolled and investigated by using Brief Psychiatric Rating Scale( BPRS),Positive and Negative Syndrome Scale( PANSS),Treatment Emergent Symptom Scale( TESS) and Clinician's Global Impressions- Severity of Illness Scale( CGI-SI). Results Both outpatients and inpatients had been discriminated and had the situation of stigma and disease concealing. After inpatient treatment,the scores of disease concealing factor and positive effect factor were 2. 01 ± 0. 88 and1. 68 ± 0. 78 respectively,which were significantly lower than those of outpatients( 2. 43 ± 0. 98 and 2. 44 ± 0. 78,respectively,P〈 0.05). Conclusion Outpatient treatment has the influence on reduce stigma and improve the life quality of schizophrenia patients in remission.
出处 《浙江预防医学》 2014年第9期893-896,共4页 Zhejiang Journal of Preventive Medicine
基金 2010神经精神转化医学科技创新团队项目资助(2010R50049) 浙江省医药卫生科技项目(2012KYA039)
关键词 门诊 住院 精神分裂症 病耻感对照研究 Outpatient Inpatient Schizophrenia Stigma
  • 相关文献

参考文献16

二级参考文献114

共引文献213

同被引文献77

  • 1高士元,费立鹏,王向群,徐东,贾志民,高维成,胥德广.精神分裂症病人及家属受歧视状况[J].中国心理卫生杂志,2005,19(2):82-85. 被引量:139
  • 2向云.精神分裂症与认知功能障碍[J].中国行为医学科学,2005,14(7):620-622. 被引量:65
  • 3赵莉,曲明阳,许晶.抑郁症患者的认知功能特征[J].中国组织工程研究与临床康复,2007,11(30):5935-5938. 被引量:12
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:108-1150.
  • 5Phillips MR,Zhang J,Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05 : an epidemiological survey [ J ]. Lancet, 2009, 373 ( 9680 ) : 2041-2053.
  • 6Bcrlim MT, Pavanello DP, Cahlleraro MA, et al. Rclinlfilily and validity of the WHOQOL BREF in a sample of Brazilian oulpa- tients with major depression [ J ]. Qual Life. Rcs. 2005,14 ( 2 ) : 561-564.
  • 7Mas-Exp6sito L, Amador-Campos JA, Gomez-Benito J, et al. The World Health Organization Quality of Life Scale Version : a valida- tion study in patients with schizophrenia [ J ]. Qual Life Res, 2011,20(7 ) : 1079-1089.
  • 8Castro PC, Driusso P, Oishi J. Convergent validity between SF-36 and WHOQOL-BREF in older adults [ J ]. Rev Saude Publica. 2014,248 ( 1 ) :63-67.
  • 9张文彤.SPSS统汁分析高级敦程[M].第2版.北京:高等教育出版社,2011,365-366.
  • 10钮伟芳,李杰,张亚红,潘十伟.WHOQOL—BREF在抑郁症患者中的应用分析[J].神经疾病与精神卫生,2009(1):56-57. 被引量:24

引证文献9

二级引证文献187

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部